The utilisation of long-acting insulin analogues and intermediate-acting insulin in patients with type 2 diabetes in the United Kingdom

被引：0

作者：

Brunetti, V. C. ^{[1
,2
]}

Yu, O. H. Y. ^{[2
,3
]}

Platt, R. W. ^{[1
,4
]}

Filion, K. B. ^{[1
,5
]}

机构：

[1] McGill Univ, Montreal, PQ, Canada

[2] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada

[3] Jewish Gen Hosp, Div Endocrinol & Metab, Montreal, PQ, Canada

[4] McGill Univ, Dept Pediat, Montreal, PQ, Canada

[5] McGill Univ, Dept Med, Montreal, PQ, Canada

来源：

DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

290

引用

页码：S146 / S146

页数：1

共 50 条

[1] The utilization of long-acting insulin analogues and intermediate-acting NPH insulin among patients with type 2 diabetes in the United Kingdom
Brunetti, Vanessa C.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 404 - 404
[2] Long-acting insulin analogs versus intermediate-acting insulin and the risk of major adverse cardiovascular events among patients with type 2 diabetes in the United Kingdom
Brunetti, Vanessa C.
Yu, Oriana
Platt, RobertW
Filion, Kristian B.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 104 - 104
[3] Intermediate-acting versus long-acting insulin for type 1 diabetes mellitus
不详
[J]. JOURNAL OF DIABETES, 2009, 1 (03) : 138 - 138
[4] A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin
Adachi, A
Fukunaga, A
Horikawa, T
[J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (08) : 597 - 599
[5] THE UTILISATION AND SWITCHING RATES OF NEUTRAL PROTAMINE HAGEDORN (NPH) INSULIN AND LONG-ACTING INSULIN ANALOGS IN PATIENTS WITH TYPE 2 DIABETES IN THE UNITED KINGDOM
Brunetti, V. C.
Yu, O. H. Y.
Platt, R. W.
Filion, K. B.
[J]. VALUE IN HEALTH, 2020, 23 : S512 - S512
[6] A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes
Chun-Ting Yang
Kuan-Ying Li
Chen-Yi Yang
Huang-Tz Ou
Shihchen Kuo
[J]. Scientific Reports, 11
[7] A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes
Yang, Chun-Ting
Li, Kuan-Ying
Yang, Chen-Yi
Ou, Huang-Tz
Kuo, Shihchen
[J]. SCIENTIFIC REPORTS, 2021, 11 (01)
[8] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
Schmid, C.
Krayenbuhl, P.
Wiesli, P.
[J]. DIABETOLOGIA, 2009, 52 (12) : 2668 - 2669
[9] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
C. Schmid
P. Krayenbühl
P. Wiesli
[J]. Diabetologia, 2009, 52 : 2668 - 2669
[10] Long-acting insulin analogues
Holt, R
[J]. DIABETES OBESITY & METABOLISM, 2003, 5 (04): : 270 - 270

← 1 2 3 4 5 →